The San Diego-based Ambrx will be forging ahead without a captain at the helm--at least for a short time. A spokesperson for the seven-year-old biotech--a promising 2005 Fierce 15 company--tells Xconomy that CEO Steve Kaldor "is taking some time off as he considers other options." She added that Kaldor and the board had decided it was time to find a new chief executive.
As biotech scribe Luke Timmerman notes, Ambrx is one of the richest developers in the San Diego hub. It's raised more than...